Experience

Mabwell Bioscience Announces Formation of Kalexo Bio With Aditum Bio

September 17, 2025

Cooley advised Mabwell Bioscience, an innovation-driven biopharmaceutical company with capabilities spanning the entire pharmaceutical value chain, on its exclusive license agreement with Aditum Bio to launch Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to develop 2MW7141, a novel dual-target small interfering RNA (siRNA) candidate for lipid management in patients with dyslipidemia and for the prevention of high-risk atherosclerotic cardiovascular disease events.

Read more

Related contacts

Charity Williams
Partner, San Diego
Freddy Yip
Associate, Hong Kong
Ken Rollins
Partner in Charge – San Diego, San Diego
Brett Dovman
Associate, San Diego
Jeffrey J. Tolin
Partner, New York
Amanda Pacheco
Associate, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
Christopher Kimball
Partner, Washington, DC
David Burns
Special Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

Hengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement

September 5, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its exclusive license agreement with Braveheart Bio for HRS-1893, a small-molecule inhibitor of cardiac myosin independently developed by Hengrui Pharma with best-in-class potential.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Freddy Yip
Associate, Hong Kong
Steve Przesmicki
Partner, San Diego
Navya Dasari
Associate, New York
Max Levinbook
Associate, San Diego
Jeffrey J. Tolin
Partner, New York
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
Christopher Kimball
Partner, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

August 6, 2025

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on an up to $500 million strategic financing agreement with funds managed by Blackstone.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Asa Henin
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Margaret Barreto
Associate, San Francisco
Charles A. Watkins II
Associate, Santa Monica
Kavi Huded
Associate, New York
Jeffrey J. Tolin
Partner, New York
David Dalton
Associate, Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Charity Williams
Partner, San Diego
Karen Tsai
Special Counsel, Washington, DC
Dr. Jon Cousin
Partner, Washington, DC
Dr. Jason Valentine
Associate, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Allison Kutner
Associate, New York
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, Colorado
Kimberly Nguyen
Special Counsel, Reston
Peter Crain
Special Counsel, Reston
Kristine Forderer
Partner, San Francisco

Related Practices & Industries

Ambiq Micro Announces Pricing of $96 Million IPO

July 30, 2025

Cooley advised Ambiq Micro, a technology leader in ultra-low-power semiconductor solutions for edge artificial intelligence, on its $96 million initial public offering (IPO).

Read more

Related contacts

Christina T. Roupas
Partner in Charge – Chicago, Chicago
Courtney M.W. Tygesson
Partner, Chicago
Michael Platt
Partner in Charge – Colorado, Colorado
Kelly Bartling
Special Counsel, Colorado
Grady Chang
Associate, Santa Monica
Keith Berets
Partner, Colorado
Will Cai
Partner, Hong Kong
Annie Froehlich
Partner, Washington, DC
Austin Holt
Partner, Santa Monica
Len Jacoby
Partner, New York
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Patrick Loofbourrow
Partner, Singapore
Barbara Mirza
Partner, Santa Monica
Tim Pitrelli
Partner, Singapore
Nicola Squire
Partner, London
Jeffrey J. Tolin
Partner, New York
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Alaina DeBona
Special Counsel, Chicago
Andrew Epstein
Special Counsel, Seattle
Brooke Fritz
Special Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Vince Sampson
Special Counsel, Washington, DC
Michael Shen
Special Counsel, Shanghai
Karen Tsai
Special Counsel, Washington, DC
Blake Martell
Of counsel, San Francisco
Mateus Kaba Aboud
Associate, Chicago
Adam Bloom
Associate, Chicago
Umer Chaudhry
Associate, Washington, DC
Stefan Cohen
Associate, New York
Megan Drill
Associate, San Diego
Ryan Guo
Associate, New York
Sarah Oliai
Associate, Washington, DC
Samuel Paullin
Associate, Chicago
Taryn Wilkins
Associate, Chicago
Katherine Duplay
Paralegal Specialist, Colorado
Alla Kagan
Paralegal Specialist, San Diego
Robin K. Lee
Paralegal Specialist, Colorado
Brian Youn
Paralegal Specialist, Palo Alto
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie

June 30, 2025

Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Edmond Lay
Partner, San Diego
Charity Williams
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
W. Chad Shear
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Stacey A. Bradford
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Alexandria Ashour
Associate, San Diego
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Tony P. Guan
Associate, Santa Monica
Michelle Hunt
Associate
Emily Mok
Associate, Reston
Jonathan Perez-Reyzin
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Christopher Suhler
Associate, Colorado
Novak Topalovic
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Rubin Waranch
Associate, Colorado
Yuhan Wu
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

View more

Admissions and credentials

New York

Rankings and accolades

The Legal 500 US: US Taxes: Non-Contentious (2024 – 2025)

Memberships and affiliations

American Bar Association - Section of Taxation

New York State Bar Association

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.